Current status and recommendations for biomarkers and biobanking in neurofibromatosis

Authors

• C. Oliver Hanemann, Peninsula Medical School
• Jaishri O. Blakeley, Johns Hopkins University
• Fabio P. Nunes, Eli Lilly
• Kent Robertson, Indiana University-Purdue University Indianapolis
• Anat Stemmer-Rachamimov, Harvard University
• Victor Mautner, University of Hamburg
• Andreas Kurtz, Charité Universitätsmedizin Berlin
• Michael Ferguson, Indiana University-Purdue University Indianapolis
• Brigitte C. Widemann, National Institutes of Health
• D. Gareth Evans, University of Manchester
• Rosalie Ferner, Guy's and St Thomas' NHS Foundation Trust
• Steven L. Carroll, Medical University of South Carolina
• Bruce Korf, University of Alabama at Birmingham
• Pierre Wolkenstein, GHU Henri Mondor
• Pamela Knight, Children's Tumor Foundation (CTF)
• Scott R. Plotkin, Harvard University

ORCID

• C. Oliver Hanemann: 0000-0002-1951-1025

Document Type

Article

DOI Link

10.1212/WNL.0000000000002932

Publication Date

2016-08-16

Publication Title

Neurology

Volume

87

ISSN

0028-3878

Acceptance Date

2016-03-30

First Page

40

Last Page

48

Recommended Citation

Hanemann, C., Blakeley, J., Nunes, F., Robertson, K., Stemmer-Rachamimov, A., Mautner, V., Kurtz, A., Ferguson, M., Widemann, B., Evans, D., Ferner, R., Carroll, S., Korf, B., Wolkenstein, P., Knight, P., & Plotkin, S. (2016) 'Current status and recommendations for biomarkers and biobanking in neurofibromatosis', Neurology, 87, pp. 40-48. Available at: 10.1212/WNL.0000000000002932